Latest news 18th May 2026 NovalGen Appoints Dr Laurent Fischer as Chair of the Board 17th March 2026 Cancer Research UK and NovalGen dose the first patient in the Phase 1 trial of T-cell engager NVG-222 VIEW ALL NEWS Publications Read our publications here VIEW ALL PUBLICATIONS
17th March 2026 Cancer Research UK and NovalGen dose the first patient in the Phase 1 trial of T-cell engager NVG-222
